Literature DB >> 17316568

A critical role for p38 map kinase in NF-kappaB signaling during intermittent hypoxia/reoxygenation.

Silke Ryan1, Walter T McNicholas, Cormac T Taylor.   

Abstract

NF-kappaB-dependent inflammatory gene expression is induced by intermittent hypoxia/reoxygenation (IHR), an event that we have hypothesized may contribute to the cardiovascular pathophysiology associated with obstructive sleep apnoea syndrome (OSAS). Here, we have investigated the cellular signaling mechanisms involved. Using an established endothelial cell in vitro model, we confirm a selective activation of the pro-inflammatory transcription factor NF-kappaB over the adaptive hypoxia-inducible factor-1 (HIF-1) in IHR-stimulated bovine aortic endothelial cells. IHR activates the I-kappaB kinase (IKK) complex, leading to phosphorylation/degradation of I-kappaB alpha. IHR activates p38 MAPK and pharmacological inhibition of p38 (using SB 203580, 10 microM) abolishes NF-kappaB activation by IHR. Furthermore, depletion of p38 using siRNA significantly reduces IHR-induced NF-kappaB activity. Thus, IHR activates NF-kappaB in an IKK-dependent manner signaled at least in part via activation of p38 MAPK.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316568     DOI: 10.1016/j.bbrc.2007.02.015

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

Review 1.  Obstructive sleep apnea syndrome and cardiovascular disease: The influence of C-reactive protein.

Authors:  Izolde Bouloukaki; Charalampos Mermigkis; Eleftherios M Kallergis; Violeta Moniaki; Eleni Mauroudi; Sophia E Schiza
Journal:  World J Exp Med       Date:  2015-05-20

Review 2.  Chronic intermittent hypoxia-induced deficits in synaptic plasticity and neurocognitive functions: a role for brain-derived neurotrophic factor.

Authors:  Hui Xie; Wing-ho Yung
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

3.  Intermittent hypoxia induces murine macrophage foam cell formation by IKK-β-dependent NF-κB pathway activation.

Authors:  Toshihiro Imamura; Orit Poulsen; Gabriel G Haddad
Journal:  J Appl Physiol (1985)       Date:  2016-07-28

4.  Systems biology analyses of gene expression and genome wide association study data in obstructive sleep apnea.

Authors:  Yu Liu; Sanjay Patel; Rod Nibbe; Sean Maxwell; Salim A Chowdhury; Mehmet Koyuturk; Xiaofeng Zhu; Emma K Larkin; Sarah G Buxbaum; Naresh M Punjabi; Sina A Gharib; Susan Redline; Mark R Chance
Journal:  Pac Symp Biocomput       Date:  2011

5.  Knockdown of augmenter of liver regeneration in HK-2 cells inhibits inflammation response via the mitogen-activated protein kinase signaling pathway.

Authors:  Ruyu Yan; Ling Zhang; Ning Xia; Qi Liu; Hang Sun; Hui Guo
Journal:  Inflamm Res       Date:  2015-05-01       Impact factor: 4.575

6.  The association between sleep-disordered breathing and aortic stiffness in a community cohort.

Authors:  Hassan A Chami; Ramachandran S Vasan; Martin G Larson; Emelia J Benjamin; Gary F Mitchell; Daniel J Gottlieb
Journal:  Sleep Med       Date:  2015-11-27       Impact factor: 3.492

Review 7.  Circulating adhesion molecules in obstructive sleep apnea and cardiovascular disease.

Authors:  Victoria M Pak; Michael A Grandner; Allan I Pack
Journal:  Sleep Med Rev       Date:  2013-04-22       Impact factor: 11.609

8.  Inhibition of Lipolysis Ameliorates Diabetic Phenotype in a Mouse Model of Obstructive Sleep Apnea.

Authors:  Martin Weiszenstein; Larissa A Shimoda; Michal Koc; Ondrej Seda; Jan Polak
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

Review 9.  Chronic intermittent hypoxia and hypertension: a review of systemic inflammation and Chinese medicine.

Authors:  Chun-Xiao Wu; Yue Liu; Jing-Chun Zhang
Journal:  Chin J Integr Med       Date:  2013-05-15       Impact factor: 1.978

Review 10.  Post-translational modification of proteins during intermittent hypoxia.

Authors:  Ganesh K Kumar; Nanduri R Prabhakar
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.